JD Health International, Inc. (HK:6618) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
JD Health International, Inc. reported a significant rise in revenue and profits for the third quarter of 2024, with revenue increasing by 14.8% and profit surging by 212.2% compared to the same period in 2023. The company expanded its pharmaceutical offerings and online medical services, enhancing its service model by integrating online consultations and at-home testing services in major cities like Beijing and Shanghai. JD Health also introduced online payment services through medical insurance accounts, further solidifying its position in the healthcare market.
For further insights into HK:6618 stock, check out TipRanks’ Stock Analysis page.